Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MRSN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MRSN investment potential.

What is MRSN stock price today?

Get real-time MRSN stock price, historical data, and price charts on Financhill. Track MRSN performance with our advanced analysis tools.

Is MRSN a good investment?

Evaluate MRSN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MRSN stock?

To buy MRSN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MRSN?

View detailed market capitalization data and company valuation metrics for MRSN on our comprehensive analysis page.

What is the P/E ratio of MRSN?

Use our fundamental analysis tools to view MRSN P/E ratio and compare valuation metrics with industry peers.

What are MRSN earnings?

View MRSN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Mersana Therapeutics, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

MRSN
Mersana Therapeutics, Inc.

Last Price:

$29.08

Seasonality Move:

-2.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

Mersana Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Mersana Therapeutics, Inc. has on average historically risen by 0.5% based on the past 8 years of stock performance.
Mersana Therapeutics, Inc. has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Is Mersana Therapeutics, Inc. Stock Undervalued?

The current Mersana Therapeutics, Inc. [MRSN] share price is $29.08. The Score for MRSN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
MRSN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Mersana Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Mersana Therapeutics, Inc. has on average historically risen by 0.5% based on the past 8 years of stock performance.

Mersana Therapeutics, Inc. Stock Rating

Sell

Mersana Therapeutics, Inc. (MRSN) is a Sell

Is Mersana Therapeutics, Inc. overpriced?

Mersana Therapeutics, Inc. has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Mersana Therapeutics, Inc. Stock Price History

Is MRSN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRSN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

mersana.com

52-Week Data

52-Week High:

30.39

52-Week Low:

5.21

Prediction Charts

Market Cap:

145M

Price in USD:

29.08

Volume:

Beta:

1.47

Technical Analysis

SMA50:

24.80

SMA100:

16.55

SMA200:

12.46

52-Wk Change:

83.47%

Stock Predictions

Is Mersana Therapeutics, Inc. stock public?

Yes, Mersana Therapeutics, Inc. is a publicly traded company.
What is the Mersana Therapeutics, Inc. stock quote today?

The Mersana Therapeutics, Inc. stock price is 29.08 USD today.
How to buy Mersana Therapeutics, Inc. stock online?

You can buy Mersana Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-23	28.88	29.00	29.07	28.85
Dec-24	29.01	29.10	29.14	29.00
Dec-26	29.10	29.08	29.15	28.91
Dec-29	28.87	28.73	29.11	28.40
Dec-30	28.56	28.65	28.98	28.11
Dec-31	28.48	28.93	28.96	28.48
Jan-5	28.90	29.08	30.39	28.78
Jan-6	29.08	29.08	29.08	29.08
Jan-7	29.08	29.08	29.08	29.08
Jan-8	29.08	29.08	29.08	29.08
Jan-9	29.08	29.08	29.08	29.08
Jan-12	29.08	29.08	29.08	29.08
Jan-13	29.08	29.08	29.08	29.08
Jan-14	29.08	29.08	29.08	29.08

Mersana Therapeutics, Inc. Earnings

Mersana Therapeutics, Inc. Earnings Report: Per Share Mersana Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mersana Therapeutics, Inc. Forecast Revenue Growth

Mersana Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Mersana Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $2.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.60 per share, and a decrease next year of $0.10 per share.

* Mersana Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.